{"id":25863,"date":"2026-04-01T11:30:18","date_gmt":"2026-04-01T09:30:18","guid":{"rendered":"https:\/\/www.maatpharma.com\/?p=25863"},"modified":"2026-04-21T11:35:06","modified_gmt":"2026-04-21T09:35:06","slug":"1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais","status":"publish","type":"post","link":"https:\/\/www.maatpharma.com\/fr\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\/","title":{"rendered":"1er avril 2026 : Third-Line Therapy Shows Limited Efficacy in Real-World aGVHD Population &#8211; Cancer Network (en anglais)"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"25863\" class=\"elementor elementor-25863\" data-elementor-settings=\"{&quot;element_pack_global_tooltip_width&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;element_pack_global_tooltip_width_widescreen&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;element_pack_global_tooltip_width_laptop&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;element_pack_global_tooltip_width_tablet_extra&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;element_pack_global_tooltip_width_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;element_pack_global_tooltip_width_mobile_extra&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;element_pack_global_tooltip_width_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;element_pack_global_tooltip_padding&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;element_pack_global_tooltip_padding_widescreen&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;element_pack_global_tooltip_padding_laptop&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;element_pack_global_tooltip_padding_tablet_extra&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;element_pack_global_tooltip_padding_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;element_pack_global_tooltip_padding_mobile_extra&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;element_pack_global_tooltip_padding_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;element_pack_global_tooltip_border_radius&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;element_pack_global_tooltip_border_radius_widescreen&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;element_pack_global_tooltip_border_radius_laptop&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;element_pack_global_tooltip_border_radius_tablet_extra&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;element_pack_global_tooltip_border_radius_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;element_pack_global_tooltip_border_radius_mobile_extra&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;element_pack_global_tooltip_border_radius_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true}}\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2b50cc7d e-flex e-con-boxed wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no wpr-equal-height-no e-con e-parent\" data-id=\"2b50cc7d\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-e61bc8e elementor-widget elementor-widget-image\" data-id=\"e61bc8e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/www.cancernetwork.com\/view\/third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population\" target=\"_blank\">\n\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"800\" height=\"459\" src=\"https:\/\/www.maatpharma.com\/wp-content\/uploads\/2026\/04\/Visuel-Publi-CHRONOS-1024x587.jpg\" class=\"attachment-large size-large wp-image-25808\" alt=\"\" srcset=\"https:\/\/www.maatpharma.com\/wp-content\/uploads\/2026\/04\/Visuel-Publi-CHRONOS-1024x587.jpg 1024w, https:\/\/www.maatpharma.com\/wp-content\/uploads\/2026\/04\/Visuel-Publi-CHRONOS-300x172.jpg 300w, https:\/\/www.maatpharma.com\/wp-content\/uploads\/2026\/04\/Visuel-Publi-CHRONOS-768x441.jpg 768w, https:\/\/www.maatpharma.com\/wp-content\/uploads\/2026\/04\/Visuel-Publi-CHRONOS.jpg 1168w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5589bb2d elementor-widget elementor-widget-text-editor\" data-id=\"5589bb2d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div style=\"text-align: center;\"><a class=\"atl-download-button\" href=\"https:\/\/www.cancernetwork.com\/view\/third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population\" target=\"_blank\" rel=\"noopener\">Pour lire l&rsquo;article, cliquer ici.<\/a><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Pour lire l&rsquo;article, cliquer ici.<\/p>\n","protected":false},"author":2,"featured_media":14416,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[36],"tags":[],"category_press":[],"year_press":[318],"class_list":["post-25863","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-media-fr","year_press-2026-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>1er avril 2026 : Third-Line Therapy Shows Limited Efficacy in Real-World aGVHD Population - Cancer Network (en anglais) - MaaT Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.maatpharma.com\/fr\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"1er avril 2026 : Third-Line Therapy Shows Limited Efficacy in Real-World aGVHD Population - Cancer Network (en anglais) - MaaT Pharma\" \/>\n<meta property=\"og:description\" content=\"Pour lire l&rsquo;article, cliquer ici.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.maatpharma.com\/fr\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\/\" \/>\n<meta property=\"og:site_name\" content=\"MaaT Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-01T09:30:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-21T09:35:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.maatpharma.com\/wp-content\/uploads\/2025\/01\/cancer-network-logo-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"MaaT Pharma\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"MaaT Pharma\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.maatpharma.com\\\/fr\\\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.maatpharma.com\\\/fr\\\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\\\/\"},\"author\":{\"name\":\"MaaT Pharma\",\"@id\":\"https:\\\/\\\/www.maatpharma.com\\\/#\\\/schema\\\/person\\\/2a1b26915c84fdbc8c7a8ebe36530d34\"},\"headline\":\"1er avril 2026 : Third-Line Therapy Shows Limited Efficacy in Real-World aGVHD Population &#8211; Cancer Network (en anglais)\",\"datePublished\":\"2026-04-01T09:30:18+00:00\",\"dateModified\":\"2026-04-21T09:35:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.maatpharma.com\\\/fr\\\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\\\/\"},\"wordCount\":22,\"publisher\":{\"@id\":\"https:\\\/\\\/www.maatpharma.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.maatpharma.com\\\/fr\\\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.maatpharma.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/cancer-network-logo-1.jpg\",\"articleSection\":[\"M\u00e9dia\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.maatpharma.com\\\/fr\\\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\\\/\",\"url\":\"https:\\\/\\\/www.maatpharma.com\\\/fr\\\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\\\/\",\"name\":\"1er avril 2026 : Third-Line Therapy Shows Limited Efficacy in Real-World aGVHD Population - Cancer Network (en anglais) - MaaT Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.maatpharma.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.maatpharma.com\\\/fr\\\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.maatpharma.com\\\/fr\\\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.maatpharma.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/cancer-network-logo-1.jpg\",\"datePublished\":\"2026-04-01T09:30:18+00:00\",\"dateModified\":\"2026-04-21T09:35:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.maatpharma.com\\\/fr\\\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.maatpharma.com\\\/fr\\\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.maatpharma.com\\\/fr\\\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.maatpharma.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/cancer-network-logo-1.jpg\",\"contentUrl\":\"https:\\\/\\\/www.maatpharma.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/cancer-network-logo-1.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.maatpharma.com\\\/fr\\\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.maatpharma.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"1er avril 2026 : Third-Line Therapy Shows Limited Efficacy in Real-World aGVHD Population &#8211; Cancer Network (en anglais)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.maatpharma.com\\\/#website\",\"url\":\"https:\\\/\\\/www.maatpharma.com\\\/\",\"name\":\"MaaT Pharma\",\"description\":\"microbiota gut to fight cancer\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.maatpharma.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.maatpharma.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.maatpharma.com\\\/#organization\",\"name\":\"Maat Pharma\",\"url\":\"https:\\\/\\\/www.maatpharma.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.maatpharma.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"http:\\\/\\\/preprod-wadesign.fr\\\/maat-pharma\\\/wp-content\\\/uploads\\\/2018\\\/09\\\/maat-logo-rvb-header.png\",\"contentUrl\":\"http:\\\/\\\/preprod-wadesign.fr\\\/maat-pharma\\\/wp-content\\\/uploads\\\/2018\\\/09\\\/maat-logo-rvb-header.png\",\"width\":150,\"height\":171,\"caption\":\"Maat Pharma\"},\"image\":{\"@id\":\"https:\\\/\\\/www.maatpharma.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.maatpharma.com\\\/#\\\/schema\\\/person\\\/2a1b26915c84fdbc8c7a8ebe36530d34\",\"name\":\"MaaT Pharma\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"1er avril 2026 : Third-Line Therapy Shows Limited Efficacy in Real-World aGVHD Population - Cancer Network (en anglais) - MaaT Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.maatpharma.com\/fr\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\/","og_locale":"fr_FR","og_type":"article","og_title":"1er avril 2026 : Third-Line Therapy Shows Limited Efficacy in Real-World aGVHD Population - Cancer Network (en anglais) - MaaT Pharma","og_description":"Pour lire l&rsquo;article, cliquer ici.","og_url":"https:\/\/www.maatpharma.com\/fr\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\/","og_site_name":"MaaT Pharma","article_published_time":"2026-04-01T09:30:18+00:00","article_modified_time":"2026-04-21T09:35:06+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/www.maatpharma.com\/wp-content\/uploads\/2025\/01\/cancer-network-logo-1.jpg","type":"image\/jpeg"}],"author":"MaaT Pharma","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"MaaT Pharma","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.maatpharma.com\/fr\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\/#article","isPartOf":{"@id":"https:\/\/www.maatpharma.com\/fr\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\/"},"author":{"name":"MaaT Pharma","@id":"https:\/\/www.maatpharma.com\/#\/schema\/person\/2a1b26915c84fdbc8c7a8ebe36530d34"},"headline":"1er avril 2026 : Third-Line Therapy Shows Limited Efficacy in Real-World aGVHD Population &#8211; Cancer Network (en anglais)","datePublished":"2026-04-01T09:30:18+00:00","dateModified":"2026-04-21T09:35:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.maatpharma.com\/fr\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\/"},"wordCount":22,"publisher":{"@id":"https:\/\/www.maatpharma.com\/#organization"},"image":{"@id":"https:\/\/www.maatpharma.com\/fr\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\/#primaryimage"},"thumbnailUrl":"https:\/\/www.maatpharma.com\/wp-content\/uploads\/2025\/01\/cancer-network-logo-1.jpg","articleSection":["M\u00e9dia"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.maatpharma.com\/fr\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\/","url":"https:\/\/www.maatpharma.com\/fr\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\/","name":"1er avril 2026 : Third-Line Therapy Shows Limited Efficacy in Real-World aGVHD Population - Cancer Network (en anglais) - MaaT Pharma","isPartOf":{"@id":"https:\/\/www.maatpharma.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.maatpharma.com\/fr\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\/#primaryimage"},"image":{"@id":"https:\/\/www.maatpharma.com\/fr\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\/#primaryimage"},"thumbnailUrl":"https:\/\/www.maatpharma.com\/wp-content\/uploads\/2025\/01\/cancer-network-logo-1.jpg","datePublished":"2026-04-01T09:30:18+00:00","dateModified":"2026-04-21T09:35:06+00:00","breadcrumb":{"@id":"https:\/\/www.maatpharma.com\/fr\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.maatpharma.com\/fr\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.maatpharma.com\/fr\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\/#primaryimage","url":"https:\/\/www.maatpharma.com\/wp-content\/uploads\/2025\/01\/cancer-network-logo-1.jpg","contentUrl":"https:\/\/www.maatpharma.com\/wp-content\/uploads\/2025\/01\/cancer-network-logo-1.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/www.maatpharma.com\/fr\/1er-avril-2026-third-line-therapy-shows-limited-efficacy-in-real-world-agvhd-population-cancer-network-en-anglais\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.maatpharma.com\/fr\/"},{"@type":"ListItem","position":2,"name":"1er avril 2026 : Third-Line Therapy Shows Limited Efficacy in Real-World aGVHD Population &#8211; Cancer Network (en anglais)"}]},{"@type":"WebSite","@id":"https:\/\/www.maatpharma.com\/#website","url":"https:\/\/www.maatpharma.com\/","name":"MaaT Pharma","description":"microbiota gut to fight cancer","publisher":{"@id":"https:\/\/www.maatpharma.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.maatpharma.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.maatpharma.com\/#organization","name":"Maat Pharma","url":"https:\/\/www.maatpharma.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.maatpharma.com\/#\/schema\/logo\/image\/","url":"http:\/\/preprod-wadesign.fr\/maat-pharma\/wp-content\/uploads\/2018\/09\/maat-logo-rvb-header.png","contentUrl":"http:\/\/preprod-wadesign.fr\/maat-pharma\/wp-content\/uploads\/2018\/09\/maat-logo-rvb-header.png","width":150,"height":171,"caption":"Maat Pharma"},"image":{"@id":"https:\/\/www.maatpharma.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.maatpharma.com\/#\/schema\/person\/2a1b26915c84fdbc8c7a8ebe36530d34","name":"MaaT Pharma"}]}},"_links":{"self":[{"href":"https:\/\/www.maatpharma.com\/fr\/wp-json\/wp\/v2\/posts\/25863","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.maatpharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.maatpharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.maatpharma.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.maatpharma.com\/fr\/wp-json\/wp\/v2\/comments?post=25863"}],"version-history":[{"count":4,"href":"https:\/\/www.maatpharma.com\/fr\/wp-json\/wp\/v2\/posts\/25863\/revisions"}],"predecessor-version":[{"id":25870,"href":"https:\/\/www.maatpharma.com\/fr\/wp-json\/wp\/v2\/posts\/25863\/revisions\/25870"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.maatpharma.com\/fr\/wp-json\/wp\/v2\/media\/14416"}],"wp:attachment":[{"href":"https:\/\/www.maatpharma.com\/fr\/wp-json\/wp\/v2\/media?parent=25863"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.maatpharma.com\/fr\/wp-json\/wp\/v2\/categories?post=25863"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.maatpharma.com\/fr\/wp-json\/wp\/v2\/tags?post=25863"},{"taxonomy":"category_press","embeddable":true,"href":"https:\/\/www.maatpharma.com\/fr\/wp-json\/wp\/v2\/category_press?post=25863"},{"taxonomy":"year_press","embeddable":true,"href":"https:\/\/www.maatpharma.com\/fr\/wp-json\/wp\/v2\/year_press?post=25863"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}